Introduction
Pancreatic adenocarcinoma is a highly aggressive malignancy with a marked propensity for invasion and early metastasis (Ellenrieder et al., 1999) . Despite progress in characterizing the biology of cancer progression, our understanding of pancreatic adenocarcinoma invasion and metastasis remains limited. A better understanding of these processes may facilitate the development of more rational therapeutic approaches.
The immunoglobulin superfamily member CEA-CAM6 is overexpressed in variety of malignancies and represents an important determinant of cancer progression Kodera et al., 1993; Scholzel et al., 2000; Ilantzis et al., 2002) . However, the mechanisms through which CEACAM6 overexpression promotes cancer progression are poorly understood. Previously, we have shown that pancreatic adenocarcinoma cell lines display differential CEA-CAM6 expression, and that cell lines overexpressing CEACAM6 exhibit greater in vivo metastatic potential (Duxbury et al., 2004) . Furthermore, post-transcriptional suppression of CEACAM6 expression inhibits the formation of pancreatic adenocarcinoma-derived liver metastases in vivo (Duxbury et al., 2004) . The contribution of CEACAM6 overexpression to the invasive phenotype of pancreatic adenocarcinoma cells has not yet been studied.
Insulin-like growth factors (IGFs) are ubiquitously expressed peptides that act as autocrine, paracrine and endocrine growth factors, both physiologically and in the context of malignancy (Macaulay, 1992; Bergmann et al., 1995) . IGF-I signaling modulates malignant cellular behavior and plays a central role in cellular invasiveness in a variety of human malignancies (Dunn et al., 1998; Long et al., 1998a; Mira et al., 1999; Datta et al., 2000; Guirouilh et al., 2000; Lazar-Molnar et al., 2000) . Both IGF-I and its tyrosine kinase receptor (IGF-IR) are overexpressed in human pancreatic tumors (Bergmann et al., 1995) and IGF-IR signaling regulates proliferation, invasiveness and angiogenic growth factor expression by these cells (Zeng et al., 2003) . The purpose of this study was to identify the effect of CEACAM6 overexpression on IGF-I-induced cellular invasiveness and to determine the roles of c-Src and Akt/PI3 K pathways in this context. Our results indicate that promotion of IGF-IR-stimulated invasiveness represents one potential mechanism through which CEA-CAM6 overexpression may promote pancreatic cancer progression.
Results

CEACAM6 overexpression increases IGF-I-stimulated cellular invasiveness and increases IGF-IR expression
To determine the effect of CEACAM6 overexpression on cellular invasiveness, CEACAM6-overexpressing clones were established from the Capan2 cell line by transfecting cells with the pIRES-eGFP mammalian expression vector containing the CEACAM6 cDNA in sense orientation (pIRES-CEACAM6). Capan2 is a well-characterized human pancreatic ductal adenocarcinoma cell line derived from the primary pancreatic tumor of a 56-year-old caucasian (Kalthoff et al., 1993; Berrozpe et al., 1994; Lohr et al., 1994; Naumann et al., 1996; Sipos et al., 2003) . Capan2 was chosen as this cell line inherently expresses very low levels of CEACAM6 (Gardner-Thorpe et al., 2002; Duxbury et al., 2004) . Following transfection, individual clones were selected and expanded on the basis of their resistance to G418. Expression of CEACAM6 in two pIRES-CEACAM6 transfectants (pIRES-CEACAM6.1 and pIRES-CEA-CAM6.2), as well as cells transfected with the basic vector lacking the CEACAM6 cDNA (pIRES-eGFP) and parental Capan2 cells, was examined by Western blot analysis (Figure 1a) . pIRES-CEACAM6.1 exhibited CEACAM6 expression 16-fold higher than that of pIRES-eGFP cells. pIRES-CEACAM6.2 CEACAM6 expression was approximately 35-fold greater than that of pIRES-eGFP. Increased cell surface CEACAM6 expression has also been confirmed by flow cytometry and immunoadhesion assay in pIRES-CEACAM6.1 and pIRES-CEACAM6.2 transfectants (data not shown). There was no significant difference in CEA-CAM6 expression between pIRES-eGFP transfectants and parental Capan2 cells.
We determined the effect of CEACAM6 overexpression on cellular invasiveness towards an IGF-I chemoattractant using a modified Matrigel Boyden chamber invasion assay. Overexpression of CEACAM6 increased cellular invasiveness toward IGF-I by 7.2-fold and 9.9-fold in pIRES-CEACAM6.1 and pIRES-CEA-CAM6.2, respectively, compared to pIRES-eGFP cells which did not differ from parental Capan2 cells in their invasiveness (Figure 1b) . Western blot analysis demonstrated upregulation of IGF-IR protein expression in both CEACAM6-overexpressing clones (Figure 2a) . We confirmed that IGF-IR mediates the increase in IGF-Istimulated invasion by incubating cells with a blocking anti-IGF-IR antibody, or control IgG, prior to performing the invasion assay. Treatment with inhibitory anti-IGF-IR monoclonal antibody, but not control IgG, largely abolished the increase in IGF-I-stimulated invasion induced by CEACAM6 overexpression (Po0.05. Figure 2b ). CEACAM6 overexpression induced a specific increase in cellular invasiveness toward IGF-I, as invasion toward 50 mg/ml epidermal growth factor was not significantly increased by overexpression of CEACAM6 (data not shown). Together, these observations indicate that CEACAM6 overexpression promotes IGF-I-stimulated invasion by upregulation of IGF-IR signaling.
Since changes in cellular proliferation could complicate interpretation of the invasion assay, we investigated the effect of CEACAM6 overexpression on cellular proliferation in the presence and absence of IGF-I. Furthermore, in order to minimize any potentially confounding effects on cellular proliferation induced by autocrine growth factors, we performed the proliferation assays with 8-hourly medium changes. Similar approaches have been shown to prevent autocrine growth factor-induced proliferation in Capan2 pancreatic adenocarcinoma cells (Murphy et al., 2001) . Over the time period and at the IGF-I concentration of relevance to the invasion assay, we observed no significant difference in cellular proliferation among pIRES-CEA-CAM6.1, pIRES-CEACAM6.2, pIRES-eGFP transfectants and parental Capan2 cells (data not shown). These findings are consistent with our previously reported observation that post-transcriptional suppression of CEACAM6 expression does not affect in vitro cellular proliferation (Duxbury et al., 2004) .
CEACAM6 overexpression increases Akt kinase activity
Next, we sought to determine the mechanism through which overexpression of CEACAM6 induces upregulation of IGF-IR expression. Levels of Akt activity modulate IGF-IR expression in pancreatic adenocarcinoma cells (Tanno et al., 2001) and we have previously shown that suppression of CEACAM6 expression decreases Akt Ser-473 phosphorylation, a marker of Akt kinase activity (Duxbury et al., 2004) . We therefore hypothesized that Akt may play a role in the upregulation of IGF-IR expression observed in CEACAM6-overexpressing transfectants. To test this hypothesis, we first determined the effect of CEACAM6 overexpression on cellular Akt kinase activity using an in vitro kinase assay, which detects phosphorylation of glycogen synthase kinase 3, a physiological substrate of Akt. Each of the pIRES-CEACAM6 transfectants demonstrated significantly higher basal Akt activity than either pIRES-eGFP transfectants or parental Capan2 cells. There was no difference in Akt activity between pIRESeGFP transfectants and parental Capan2 cells (Figure 3a) . Total Akt levels were unchanged by the transfections.
In order to determine whether Akt activity is necessary for the upregulation of IGF-IR expression exhibited by pIRES-CEACAM6.2, we inhibited Akt activity in these cells using a dominant negative Akt expression construct (Akt (K179M)). Transfection of dominant negative Akt attenuated IGF-IR expression in pIRES-CEACAM6.2 (Figure 3b ), whereas transfection of control empty vector had no effect on pIRES-CEACAM6.2 transfectant IGF-IR expression. Conversely, expression of constitutively active myristoylated Akt (myr-Akt) in pIRES-eGFP transfectants increased IGF-IR protein expression. The effects of Akt modulation on IGF-I-induced invasiveness ( Figure 3c ) were consistent with the changes in IGF-IR expression and, taken together, these observations indicate that Akt kinase activity is both necessary and sufficient to increase IGF-IR expression and suggest that the increase in IGF-I-stimulated cellular invasiveness induced by CEACAM6 overexpression occurs through Akt-dependent signaling.
CEACAM6 overexpression increases c-Src kinase activity which is necessary, but not sufficient, to enhance IGF-IR upregulation induced by overexpression of CEACAM6
The c-Src kinase is able to activate Akt directly (Jiang and Qiu, 2003) . Given that CEACAM family members are known to associate with Src family kinases (Skubitz et al., 1995) , we hypothesized that c-Src may play a role in activating Akt. c-Src kinase activity was measured by in vitro kinase assay and, consistent with our hypothesis, both pIRES-CEACAM6 transfectants demonstrated significantly elevated c-Src kinase activity, compared to both pIRES-eGFP transfectants and Capan2 cells, which showed no difference in their relative c-Src kinase activities ( Figure 4a ). Furthermore, functional inhibition of c-Src kinase in pIRES-CEACAM6.2 by expression of dominant negative c-Src (Src (K296R/Y528F)) markedly attenuated IGF-IR expression, indicating that c-Src kinase is necessary for the increase in IGF-IR expression induced by overexpressing CEACAM6 in these cells.
Next, we sought to clarify whether increased c-Src kinase is sufficient to induce upregulation of IGF-IR in the absence of Akt activation. pIRES-eGFP transfectants were cotransfected with constitutively active c-Src (Src (Y529F)) and dominant negative Akt constructs (Akt (K179M), Figure 4b ). Cotransfected cells exhibited no significant change in IGF-IR expression. Changes in IGF-I-mediated cellular invasiveness corresponded to the effects on IGF-IR expression (Figure 4c) , a finding which, taken together with our other data, indicates that while c-Src kinase activity is required for the increase in IGF-IR expression and IGF-I-induced invasiveness exhibited by pIRES-CEACAM6.2 transfectants, it alone is not sufficient to upregulate IGF-IR expression and IGF-I-induced invasiveness in the presence of Akt inhibition. In contrast, Akt is both necessary and sufficient to upregulate IGF-IR expression and IGF-Iinduced invasiveness. This hypothesis is further supported by the results of cotransfection of dominant negative Src together with active Akt, which resulted in upregulation of IGF-IR expression and IGF-I-induced invasiveness in pIRES-eGFP cells.
CEACAM6 overexpression increases IGF-I-induced MMP-2 expression and activity
Increased invasiveness induced by Akt overactivity is associated with decreased proteosomal degradation of MMP-2 (Park et al., 2001) and we have previously shown MMP-2 to be an important determinant of Srcdependent pancreatic adenocarcinoma cellular invasiveness (Ito et al., 2003) . In addition, IGF-I is reported to increase tumor invasiveness by inducing expression of membrane type 1 matrix metalloproteinase, a principal activator of MMP-2 via PI3K/Akt signaling (Zhang and Brodt, 2003) . We therefore quantified MMP-2 activity in the supernatants overlying both pIRES-CEACAM6 transfectants and control cells and determined levels of MMP-2 expression in lysates from these cells by Western analysis, following exposure to 20 ng/ml IGF-I for 6 h. Both pIRES-CEACAM6 transfectants demonstrated significantly greater supernatant MMP-2 activity and cellular MMP-2 expression in response to IGF-I than either pIRES-eGFP or Capan2 cells (Figure 5a ). In order to define the role of MMP-2 in the increased invasiveness observed in CEACAM6-overexpressing cells, the invasion assay was performed in the presence of 10 mg/ml anti-MMP-2 antibody. Anti-MMP-2 antibody administration inhibited the cellular invasiveness of CEACAM6-overexpressing cells by 83% in the case of pIRES-CEACAM6.1 and by 91% in the case of pIRES-CEACAM6.2 (Po0.05. Figure 5b) .
Discussion
Deregulated overexpression of CEACAM6 is a common feature of human malignancies Kodera et al., 1993; Scholzel et al., 2000) , but the mechanisms through which CEACAM6 promotes disease progression are poorly understood. CEACAM6 is a glycosylphosphatidylinositol-linked protein and lacks an intracellular domain. Despite this structural feature, CEACAM6 is capable of transducing intracellular signals, in addition to serving as an Figure 5 CEACAM6 overexpression is associated with increased MMP-2. (a) Biotrack assay was performed for MMP-2 activity in culture supernatants and Western blot analysis was performed for MMP-2 expression in lysates derived from pIRES-CEACAM6.1, pIRES-CEACAM6.2 and pIRES-eGFP transfectants exposed to 20 ng/ml IGF-I for 10 h. Overexpression of CEACAM6 is associated with increased supernatant MMP-2 activity and cellular MMP-2 expression. Blot shown is representative of three independent determinations. Densitometry values are mean (7 s.d. (Kuroki et al., 2001) . In this study, we determined the effect of CEACAM6 overexpression on IGF-I-stimulated invasiveness. We have demonstrated that transfectants stably overexpressing CEACAM6 exhibit increased IGF-IR expression and enhanced IGF-I-stimulated invasiveness. Our findings also illustrate the central role of Akt and c-Srcdependent signaling in this phenomenon. IGF-IR is overexpressed by a variety of human malignancies, including pancreatic adenocarcinoma (Bergmann et al., 1995; Ouban et al., 2003) . Numerous studies have demonstrated that both overexpression and overactivity of IGF-IR are associated with malignant transformation, increased tumor aggressiveness and protection from apoptosis (Kaleko et al., 1990; Macaulay, 1992; Sell et al., 1995; Wu et al., 1996; Prisco et al., 1997) . Circulating IGF-I levels modulate gastrointestinal tumor growth and liver metastasis in vivo (Wu et al., 2002) , and IGF-I stimulates cellular invasiveness and metastasis in human tumors including pancreatic adenocarcinoma (Stracke et al., 1989; Long et al., 1998a b; Tanno et al., 2001) . Conversely, recent studies have shown that IGF-IR plays a crucial role in induction and maintenance of the malignant cellular phenotype . Overexpression of IGF-IR induces transformation of a variety of cell types and previous reports have shown that increased tumor cell IGF-IR expression enhances cellular invasiveness (Long et al., 1998a, b) . Inhibition of IGF-IRmediated signaling using a range of strategies suppresses in vitro and in vivo tumor cell growth (Pietrzkowski et al., 1993; Baserga et al., 1994 Baserga et al., , 1997 Resnicoff et al., 1994; Burfeind et al., 1996; Li et al., 2000) . Interestingly, despite being an important mitogenic factor in pancreatic adenocarcinoma, pancreatic adenocarcinoma cells reportedly do not express IGF-I. Rather, IGF-I produced by surrounding stromal cells appears to act in a paracrine manner (Bergmann et al., 1995) . Matrigel, which was used in the invasion assay, contains extracellular matrix components such as laminin and collagen IV and closely resembles the tumor microenvironment (Kleinman et al., 1982 (Kleinman et al., , 1986 . Tumor cell invasion depends upon the ability of cells to reorganize extracellular matrix components, which is achieved in part by secretion of proteolyic enzymes such as the matrix metalloproteinases (MMPs). Previous reports have indicated that IGF-I induces tumor cell expression of extracellular matrix proteinases, including MMP-2 (Long et al., 1998a) . MMP-2 expression is increased in M-27 lung carcinoma cells induced to overexpress wildtype IGF-IR (Brodt et al., 2001) . Furthermore, IGF-I selectively regulates expression of MMP-2 in transformed cells through stabilization of MMP-2 mRNA (Yoon and Hurta, 2001 ). In our study, MMP-2 expression in response to IGF-I was increased in both CEACAM6-overexpressing clones of the Ras mutant cell line Capan2. Overexpression of MMP-2, due to augmented IGF-I signaling induced by CEACAM6 overexpression, may therefore contribute to the increased cellular invasiveness observed in our model. Modulation of CEACAM6 expression specifically influences liver metastasis in the nude mouse xenograft model (Duxbury et al., 2004) and IGF-I signaling is of particular importance in liver colonization by carcinoma cells (Long et al., 1994 (Long et al., , 1998b Wu et al., 2002) . IGF-I is expressed by hepatocytes (Long et al., 1994) which, through paracrine signaling, may contribute to the increased propensity for liver metastasis seen in cells overexpressing CEACAM6.
Levels of IGF-IR expression are correlated with proliferation of pancreatic adenocarcinoma cells (Zeng et al., 2003) , and overexpression of kinase-activated cSrc has been reported to increase IGF-I-induced pancreatic adenocarcinoma cellular proliferation through upregulation of IGF-IR (Flossmann-Kast et al., 1998). However, we were able to confirm that the effect of CEACAM6 overexpression on cellular invasiveness was not an artefact of altered cellular proliferation, despite upregulation on IGF-IR expression in pIRES-eGFP transfectants. Our results also appear to be more broadly applicable, as BxPC3 cells, which inherently overexpress CEACAM6, exhibit significant cellular invasiveness towards IGF-I that is attenuated by suppression of CEACAM6 expression (Duxbury et al., unpublished data) .
Expression of active and dominant negative Akt demonstrated that Akt signaling is both necessary and sufficient to induce IGF-IR expression and enhance IGF-I-stimulated invasiveness. The role of c-Src differed from that of Akt in that c-Src kinase activity was necessary but not sufficient to increase IGF-IR expression and IGF-I-stimulated invasiveness. These observations are consistent with the current paradigm of SrcAkt signaling: It has recently been recognized that c-Src directly activates Akt through an interaction between its SH3 domain and a conserved proline-rich motif in the C-terminal regulatory region of Akt (Jiang and Qiu, 2003) . Previously, we have shown that inhibition of Src family tyrosine kinase activity suppresses pancreatic adenocarcinoma cellular invasiveness (Ito et al., 2003) . Furthermore, we have shown that inhibition of CEA-CAM6 expression reduces Akt phosphorylation at Ser-473, an indicator of Akt activity directly influenced by c-Src activity (Downward, 1998) . CEACAM family molecules have been reported to associate with Src family kinases (Skubitz et al., 1995) . Although this study was not designed to address the molecular interaction between CEACAM6 and c-Src, we observed that CEACAM6 overexpression increased c-Src kinase activity. Overactivity of c-Src and Akt have been reported to increase IGF-I-induced invasiveness in pancreatic adenocarcinoma cells and our results are consistent with the findings of that study (Tanno et al., 2001) . The mechanisms through which Akt induces expression of IGF-IR is not fully characterized, although levels of PI3K/Akt activity may regulate IGF-IR expression at both the transcriptional level and at the post-transcriptional level, through translational regulators such as eIF4E (Sonenberg and Gingras, 1998) . Further studies are required to define the regulatory mechanisms governing IGF-IR expression.
Although the observed effects of CEACAM6 overexpression on IGF-I-stimulated invasiveness may contribute to increased tumor progression in vivo, other mechanisms appear to contribute. Work originally reported by Ordonez et al (2000) , and work reported by our own group in pancreatic adenocarcinoma cells (Duxbury et al., 2004) , demonstrating that CEACAM6 gene silencing attenuates cellular resistance to anoikis may also be relevant. Resistance to apoptosis induced by inadequate or inappropriate cell-substrate contact is associated with enhanced tumorigenesis, cellular invasion and metastatic ability (Yawata et al., 1998; Streuli and Gilmore, 1999; Shanmugathasan and Jothy, 2000) . Suppression of CEACAM6 expression may also impair disease progression through a reduction in resistance to anoikis.
In summary, overexpression of CEACAM6 enhances IGF-I-stimulated cellular invasiveness. Increased invasiveness following CEACAM6 overexpression is associated with upregulation of IGF-IR expression, which depends upon Akt activation induced by CEACAM6 overexpression. c-Src tyrosine kinase is necessary, but not sufficient, for IGF-IR upregulation secondary to CEACAM6 overexpression. These consequences of CEACAM6 overexpression may contribute to its ability to act as an oncoprotein. Targeting CEACAM6 and its downstream pathways represents a rational approach for the development of novel pancreatic cancer therapies.
Materials and methods
Cell culture
Capan2 pancreatic ductal adenocarcinoma cells were obtained from ATCC (Rockville, MD, USA). Cells express very low levels of CEACAM6 and CEA (Gardner-Thorpe et al., 2002; Sipos et al., 2003; Duxbury et al., 2004) . Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS, Gibco BRL, Gaithersburg, MD, USA). Cells were incubated in a humidified (371C, 5% CO 2 ) incubator and passaged upon reaching 80% confluence.
Plasmid constructs and transfection
Poly-A RNA was reverse transcribed using an anchored oligodT primer with an XhoI restriction site. Double-stranded CEACAM6 cDNA was prepared and ligated into EcoRI adaptors, digested with XhoI, ligated into the pOTB7 vector and transferred to the pIRES-eGFP expression plasmid (the CEACAM6 containing construct is termed pIRES-CEA-CAM6). Cells were transfected with pIRES-CEACAM6 or pIRES-eGFP, which acted as a control, using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer's protocol. Stable clones were selected by continuous treatment with G418 (Gibco, 0.8 mg/ml) over 4 weeks. Constitutively active Src (Y529F) and Akt (myr-Akt), and dominant negative Src ((k296R/Y528F) and Akt (K179M) expression constructs were obtained from Upstate (Waltham, MA, USA). Transfection was performed in the same manner.
Western blot analysis
Cells were washed with ice-cold PBS and whole-cell extracts were prepared using cell lysis buffer (20 mM Tris, pH 7.5, 0.1% Triton X, 0.5% deoxycholate, 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin) and cleared by centrifugation at 12 000 g, 41C. Total protein concentration was measured using the BCA assay kit (Sigma, St Louis, MO, USA) with bovine serum albumin as a standard. Cell lysates containing 30 mg total protein were analysed by immunoblotting. Anti-CEA-CAM6 antibody was obtained from InnoGenex (San Ramon, CA, USA). This antibody is noncrossreactive with other closely related CEACAM family members (Mayne et al., 1993; Tooze et al., 1995) . Anti-IGF-IR-beta antibody was obtained from Chemicon (Temecula, CA, USA). Anti-MMP-2 and antiactin antibodies were obtained from LabVision (Freemont, CA, USA). Chemoluminescent detection (Upstate, Lake Placid, NY, USA) was performed in accordance with the manufacturer's instructions. The CEACAM6 signal was quantified using ImagePro Plus software version 4.0 and normalized to that of actin.
In vitro cellular invasion assay
Cell invasion assays were performed using Transwell membrane filter inserts with 8 mm pore size (Corning Costar, Cambridge, MA, USA). The upper surface of the Transwell membrane was coated with 250 mg/ml growth factor-reduced Matrigel matrix (Becton Dickinson, Bedford, MA, USA) overnight at 41C, rehydrated once with 0.1% BSA in DMEM for 1 h at room temperature, and then placed in the upper compartment of six-well tissue culture plates. At 24 h after transfection, cells were removed from tissue culture flasks by trypsinization and washed once in PBS. Then, 2 Â 10 5 cells in serum-free medium containing 0.1% BSA were added to each Transwell chamber and allowed to migrate toward the underside of the membrane for 10 h with and without 20 ng/ ml IGF-I (Sigma) in the lower chamber as a chemoattractant. After cells were fixed in 3.5% paraformaldehyde, cells on the upper surface of the membrane were removed by wiping with a cotton swab. The number of invading cells transfected with empty vector was assigned a value of 1.0 in each experiment. A total of 10 random fields/membrane were counted for each assay. Each determination represents the mean of three separate experiments. The effect of IGF-IR antagonism was determined by incubation of cells in medium containing 10 mg/ ml of either the inhibitory aIR-3 anti-IGF-IR monoclonal antibody (EMD Biosciences, San Diego, CA, USA) of control IgG, prior to performing the invasion assay. Anti MMP-2 antibody was used at 10 mg/ml in the same manner.
MMP-2 activity assay
Activity of the matrix metalloproteinase MMP-2 in cell culture supernatants from wells seeded with 10 5 pancreatic adenocarcinoma cells was quantified after culture for 6 h in fresh serumfree DMEM containing 20 ng/ml IGF-I, or DMSO vehicle, using the Biotrak activity assay (Amersham Biosciences Corp., Piscataway, NJ, USA) in accordance with the manufacturer's instructions. Plates were read at 405 nm using a Vmax microplate spectrophotometer (Molecular Devices, Sunnyvale, CA, USA). Four samples were used for each determination and experiments were performed in triplicate.
Cell proliferation assay
Cell proliferation was quantified by 3-(4,5,-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Trevigen, Gaithersburg, MD, USA) in accordance with the manufacturer's instructions. Results of the MTT assay have been shown to correlate well with [ 3 H]thymidine incorporation in pancreatic adenocarcinoma cell lines (Raitano et al., 1990) . Cells were seeded into 96-well plates at 10 4 cells per well and allowed to adhere overnight in medium containing 10% FBS. Cell viability was determined after 24 h. Plates were read using a Vmax microplate spectrophotometer (Molecular Devices, Sunnyvale, CA, USA) at a wavelength of 570 nm, referenced to 650 nm. A total of 10 samples were used for each experimental condition and experiments were performed in triplicate. At identical time points, cell counting was performed. Cells were trypsinized to form a single-cell suspension. Viable cells, determined by Trypan blue exclusion, were counted using a Neubauer hemocytometer (Hausser scientific, Horsham, PA, USA). Cell counts were used to confirm MTT results.
In vitro Akt kinase assay
Akt activity was quantified using a commercially available nonradioactive in vitro kinase assay, in accordance with the manufacturer's instructions (Cell Signaling Technology, Beverly, MA, USA). Akt was immunoprecipitated from 200 ml cell lysates containing equal total protein. The resulting immunoprecipitates were incubated with GSK-3 fusion protein in the presence of ATP and kinase buffer. Phosphorylation of GSK-3 was quantified by Western Blot, using anti-phospho-GSK-3a/b (Ser 21/9) antibody. Blots were performed in triplicate.
c-Src kinase assay
c-Src tyrosine kinase activity was determined in triplicate using a commercially available kinase assay kit (Sigma, St Louis MO, USA), according to the manufacturer's instructions. c-Src immunoprecipitates (20 mg total protein) were prepared using anti-c-Src monoclonal antibody immobilized onto protein G sepharose beads (Zymed Laboratories Inc., San Francisco, CA, USA). Immunoprecipitates were washed and dissolved in tyrosine kinase buffer (final solution containing 0.3 mM ATP) and incubated for 30 min in 96-well plates coated with tyrosine kinase substrate solution (poly-Glu-Tyr). Phosphorylated substrate was quantified by chromogenic detection using horseradish peroxidase-conjugated anti-phosphotyrosine antibody. Optical densities were determined at 492 nm using a Vmax microplate spectrophotometer. c-Src kinase activity was compared to an epidermal growth factor receptor standard. Experiments were performed in triplicate with four determinations for each condition.
Statistical analysis
Differences between groups were analysed using Student's t-test, multifactorial ANOVA of initial measurements and Mann-Whitney U-test, for nonparametric data, as appropriate, using Statistica 5.5 software (StatSoft, Inc., Tulsa, OK, USA). In cases where averages were normalized to controls, the standard deviations of each nominator and denominator were taken into account in calculating the final standard deviation. The P o 0.05 was considered statistically significant.
